Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers.

George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O'Malley SS, Bishai R, Rawlings RR, Kunos G.

Psychopharmacology (Berl). 2010 Jan;208(1):37-44. doi: 10.1007/s00213-009-1704-3. Epub 2009 Nov 10.

PMID:
19902183
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats.

Gessa GL, Serra S, Vacca G, Carai MA, Colombo G.

Alcohol Alcohol. 2005 Jan-Feb;40(1):46-53. Epub 2004 Dec 6.

PMID:
15582988
[PubMed - indexed for MEDLINE]
Free Article
3.

CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men.

Goodwin RS, Baumann MH, Gorelick DA, Schwilke E, Schwope DM, Darwin WD, Kelly DL, Schroeder JR, Ortemann-Renon C, Bonnet D, Huestis MA.

Am J Drug Alcohol Abuse. 2012 Jan;38(1):114-9. doi: 10.3109/00952990.2011.600398. Epub 2011 Jul 29.

PMID:
21797816
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial.

Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF; ACTOL Study Investigators.

J Clin Psychopharmacol. 2008 Jun;28(3):317-24. doi: 10.1097/JCP.0b013e318172b8bc.

PMID:
18480689
[PubMed - indexed for MEDLINE]
5.

The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.

Colombo G, Orrù A, Lai P, Cabras C, Maccioni P, Rubio M, Gessa GL, Carai MA.

Mol Neurobiol. 2007 Aug;36(1):102-12. Epub 2007 Jul 3. Review.

PMID:
17952655
[PubMed - indexed for MEDLINE]
6.

Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.

Naranjo CA, Poulos CX, Lanctôt KL, Bremner KE, Kwok M, Umana M.

Addiction. 1995 Jul;90(7):893-905.

PMID:
7663312
[PubMed - indexed for MEDLINE]
7.
8.

Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.

Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R.

Psychopharmacology (Berl). 2006 Jan;183(4):394-403. Epub 2005 Oct 29.

PMID:
16261315
[PubMed - indexed for MEDLINE]
9.

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.

Duarte C, Alonso R, Bichet N, Cohen C, Soubrié P, Thiébot MH.

Neuropsychopharmacology. 2004 May;29(5):911-20.

PMID:
14694354
[PubMed - indexed for MEDLINE]
Free Article
10.

Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.

Maccioni P, Pes D, Carai MA, Gessa GL, Colombo G.

Behav Pharmacol. 2008 May;19(3):197-209. doi: 10.1097/FBP.0b013e3282fe8888.

PMID:
18469537
[PubMed - indexed for MEDLINE]
11.

The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats.

Dyr W, Ligieza J, Kostowski W.

Alcohol. 2008 Sep;42(6):509-12. doi: 10.1016/j.alcohol.2008.04.001. Epub 2008 May 27.

PMID:
18504086
[PubMed - indexed for MEDLINE]
12.

Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.

Yu LL, Wang XY, Zhao M, Liu Y, Li YQ, Li FQ, Wang X, Xue YX, Lu L.

Psychopharmacology (Berl). 2009 Jun;204(2):203-11. doi: 10.1007/s00213-008-1450-y. Epub 2009 Jan 16.

PMID:
19148622
[PubMed - indexed for MEDLINE]
13.

A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers.

Lukas SE, Penetar D, Su Z, Geaghan T, Maywalt M, Tracy M, Rodolico J, Palmer C, Ma Z, Lee DY.

Psychopharmacology (Berl). 2013 Mar;226(1):65-73. doi: 10.1007/s00213-012-2884-9. Epub 2012 Oct 16.

PMID:
23070022
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.

Maccioni P, Colombo G, Carai MA.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):55-9. Review.

PMID:
20201816
[PubMed - indexed for MEDLINE]
15.

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.

López-Moreno JA, González-Cuevas G, Navarro M.

Neurobiol Dis. 2007 Feb;25(2):274-83. Epub 2006 Oct 24.

PMID:
17067804
[PubMed - indexed for MEDLINE]
16.

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.

Horder J, Cowen PJ, Di Simplicio M, Browning M, Harmer CJ.

Psychopharmacology (Berl). 2009 Jul;205(1):85-91. doi: 10.1007/s00213-009-1517-4. Epub 2009 Apr 1.

PMID:
19337726
[PubMed - indexed for MEDLINE]
17.

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ.

Psychopharmacology (Berl). 2002 Feb;160(1):19-29. Epub 2002 Jan 22.

PMID:
11862370
[PubMed - indexed for MEDLINE]
18.

Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.

Li F, Fang Q, Liu Y, Zhao M, Li D, Wang J, Lu L.

Eur J Pharmacol. 2008 Jul 28;589(1-3):122-6. doi: 10.1016/j.ejphar.2008.04.051. Epub 2008 May 6.

PMID:
18534572
[PubMed - indexed for MEDLINE]
19.

Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.

Forget B, Coen KM, Le Foll B.

Psychopharmacology (Berl). 2009 Sep;205(4):613-24. doi: 10.1007/s00213-009-1569-5. Epub 2009 May 30.

PMID:
19484221
[PubMed - indexed for MEDLINE]
20.

Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.

Penberthy JK, Hook JN, Vaughan MD, Davis DE, Wagley JN, Diclemente CC, Johnson BA.

Alcohol Clin Exp Res. 2011 Sep;35(9):1694-704. doi: 10.1111/j.1530-0277.2011.01516.x. Epub 2011 Jun 15.

PMID:
21676008
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk